ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $884,652 | +92.9% | 132,433 | +142.3% | 0.00% | – |
| Q2 2023 | $458,497 | -82.9% | 54,648 | -79.7% | 0.00% | -100.0% |
| Q1 2023 | $2,676,433 | +508.6% | 269,530 | +326.6% | 0.00% | – |
| Q4 2022 | $439,747 | -42.7% | 63,182 | -63.4% | 0.00% | – |
| Q1 2022 | $768,000 | -46.3% | 172,798 | -51.6% | 0.00% | – |
| Q4 2021 | $1,430,000 | +80.8% | 357,356 | +296.3% | 0.00% | – |
| Q3 2021 | $791,000 | -4.7% | 90,182 | +23.1% | 0.00% | – |
| Q2 2021 | $830,000 | +113.9% | 73,242 | +124.4% | 0.00% | – |
| Q1 2021 | $388,000 | -29.8% | 32,645 | -59.5% | 0.00% | – |
| Q4 2020 | $553,000 | +325.4% | 80,560 | +360.1% | 0.00% | – |
| Q3 2020 | $130,000 | -76.3% | 17,509 | -86.7% | 0.00% | – |
| Q2 2020 | $549,000 | +594.9% | 131,590 | +1100.5% | 0.00% | – |
| Q3 2017 | $79,000 | – | 10,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |